V015-3934 Screening compound: N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)cyclopropanecarboxamide

V015-3934 Screening compound: N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)cyclopropanecarboxamide
V015-3934 Screening compound: N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)cyclopropanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-3934
N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)cyclopropanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-3934

Molecular Formula

C27H40FN5O (C27 H40 FN5 O)

Compound Name

N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)cyclopropanecarboxamide

IUPAC name

N-{[3-ethyl-1-(4-fluorophenyl)-5-[4-(propan-2-yl)piperazin-1-yl]-1H-pyrazol-4-yl]methyl}-N-(2-methylpropyl)cyclopropanecarboxamide

SMILES

CCc(c(CN(CC(C)C)C(C1CC1)=O)c1N(CC2)CCN2C(C)C)nn1-c(cc1)ccc1F

InChI

InChI=1S/C27H40FN5O/c1-6-25-24(18-32(17-19(2)3)27(34)21-7-8-21)26(31-15-13-30(14-16-31)20(4)5)33(29-25)23-11-9-22(28)10-12-23/h9-12,19-21H,6-8,13-18H2,1-5H3

InChI Key

MQRHHOQCHLHYJS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19942053

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

469.65

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.322

Distribution Coefficient, logD

2.893

Water Solubility, LogSw

-5.22

Polar Surface Area

38.202

Acid Dissociation Constant (pKa)

22.33

Base Dissociation Constant (pKb)

9.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.00

V015-3934 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS BBB Library (22607 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V015-3934 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-3934?
Check Price and Availability of V015-3934, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-3934 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-3934
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-3934
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-3934 available by request